Company profile
PFIZER INC
NYSE:PFEBiotechnology: Pharmaceutical Preparations
Drug pipeline (962)
| Asset | Stage | Revenue | Trials | Status |
|---|---|---|---|---|
| VYNDAQEL | approved | $1.8BQ2 2026 | 9 | approved |
| PREVNAR | approved | $1.3BQ2 2026 | 0 | — |
| PREVNAR 13 | approved | $1.3BQ2 2026 | 0 | — |
| PREVNAR 20 | approved | $1.3BQ2 2026 | 0 | — |
| IBRANCE | approved | $1.1BQ2 2026 | 28 | approved |
Revenue is the latest quarter the company reported for that product, from SEC filings; a fourth quarter is the year less nine months when no filing states one. Trial counts are of the product's ingredients, deduplicated by trial, so products sharing an ingredient share trials.
Clinical trials (3544)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT00139750 | phase2 | completed | 2004-12-01 | — | Pfizer | 12 Week Evaluation of the Safety and Efficacy of 3 Doses of CP-526,555 and Placebo for Smoking Cessation |
| NCT00150254 | phase2 | completed | 2001-09-01 | — | Pfizer | 12 Week Evaluation of the Safety and Efficacy of 4 Dosing Strategies of CP-526,555 and Placebo for Smoking Cessation. |
| NCT00150228 | phase2 | completed | 2001-12-01 | — | Pfizer | 12 Week Evaluation of the Safety and Efficacy of a Flexible Dose of CP-526,555 and Placebo for Smoking Cessation |
| NCT00159757 | phase4 | terminated | 2003-11-01 | — | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 12 Week Open, Non-Comparative Switch Study Of Oral Ziprazidone In Previously Treated Schizophrenic Patients |
| NCT00473525 | phase2 | completed | 2007-07-01 | 2008-06-01 | Pfizer | 12 Week Study Of PF-00734200 For The Treatment Of Type 2 Diabetes Mellitus In Subjects Treated With Metformin |
FDA applications (1086)
| Application | Approved | Type | Applicant | Products | ||||
|---|---|---|---|---|---|---|---|---|
| ANDA 217459 | 2025-09-11 | ANDA | HOSPIRA INC | |||||
Loading… | ||||||||
| BLA 761369 | 2024-10-11 | BLA | PFIZER INC. | |||||
Loading… | ||||||||
| BLA 125786 | 2024-04-25 | BLA | PFIZER INC. | |||||
Loading… | ||||||||
| NDA 217439 | 2024-03-07 | NDA | PFIZER INC | |||||
Loading… | ||||||||
| BLA 125770 | 2023-10-20 | BLA | PFIZER IRELAND PHARMACEUTICALS UNLIMITED COMPANY | |||||
Loading… | ||||||||